Accuracy of Italian Classification Strategy for Predicting Malignancy of Pediatric Thyroid Nodules
Researchers defined the clinical features of pediatric patients with thyroid nodules in order to assess the risk of malignancy.
Thyroid Cancer
American Heart Association Releases Statement on Cardiotoxicity During Cancer Treatment
The American Heart Association released a statement regarding cardiac toxicities and their management in patients with arrhythmic complications while undergoing treatment for cancer.
Epigenetic Clock May Reveal Biological Aging After Cancer Treatment and Allow for Objective Measurement of Fatigue
Researchers found associations between epigenetic age acceleration, inflammation, and fatigue in cancer patients.
Trends in Obesity-Related Cancer, Heart Disease Mortality During the Past 20 Years
Researchers from the University of North Carolina at Chapel Hill analyzed mortality data to determine whether causes of death related to obesity and cancer were associated with trends over time.
Cabozantinib Improved PFS, May Be New Standard for Radioiodine-Refractory Thyroid Cancer
Cabozantinib significantly improved progression-free survival, and there was a trend toward improved overall survival.
Pediatric Thyroid Nodules: Malignancy Linked to Radiation Exposure
Researchers evaluated the utility of ultrasound characteristics for refining malignancy risk to inform the management of cytologically indeterminate pediatric thyroid nodules.
Mutational Risk Not Associated With Distant Metastasis in Medullary Thyroid Cancer
Researchers identified risk factors for distant metastasis in sporadic and hereditary medullary thyroid cancer.
Increasing Global Trend of Pediatric Thyroid Cancer May Indicate Pattern of Overdiagnosis
Investigators assessed global patterns and trends in the incidence of and mortality associated with thyroid cancer in children and adolescents.
Dysglycemia Linked With Advanced Thyroid Cancer in Those Aged 55 Years or Older
Study authors performed a retrospective review of a thyroid cancer cohort to evaluate the association between metabolic health and severity of thyroid cancer.
Cabozantinib Gets Breakthrough Tx Status for Differentiated Thyroid Cancer
The designation is supported by data from the randomized, double-blind, placebo-controlled phase 3 COSMIC-311 study.
- Loading...
Loading...
Next post in Thyroid
Loading... 
Loading...